5 DJIA Earnings Previews For Tuesday (KO, INTC, IBM, JNJ, UNH)
Oct 15th 2012 1:02PM
Tuesday will bring earnings reports from five different DJIA components. There are not many days where one-fifth a major index report earnings. In the early morning hours we will get earnings reports from Coca-Cola Co. (NYSE: KO), Johnson & Johnson (NYSE: JNJ), and UnitedHealth Group Inc. (NYSE: UNH). The two DJIA reports in the afternoon after the close of trading will be from Intel Corporation (NASDAQ: INTC) and International Business Machines Corp. (NYSE: IBM). We have used consensus estimates from Thomson Reuters, shown how the stocks have been performing, and added in some trader color if applicable.
Coca-Cola Co. (NYSE: KO) trades around $38.20 and shares are down about from the $40.67 high. As a reminder, this stock split on a 2-for-1 basis over the last quarter. Estimates are $0.50 EPS and almost $12.4 billion. The estimates for fiscal 2012 are $2.00 EPS and $48.24 billion in revenue.
Intel Corp. (NASDAQ: INTC) has been suffering with slower PC sales and with the market softening on consumer device purchases using its processors. Intel warned that revenue would fall short of estimates before the quarter ended. We will be looking to see how much longer it will be before Intel processors start to really appear in smartphones and other mobile web access devices. At $21.85 its 52-week range is $21.40 to $29.27. The dividend yield is now 4.2%. Estimates are $0.53 EPS and $13.62 billion in revenue, For the next quarter estimates are $0.67 EPS and $14.85 billion in sales.
International Business Machines Corp. (NYSE: IBM) has recovered handily from its lows since the last earnings report. IBM is now effectively all under control of new CEO Virginia Rometty now that Sam Palmisano has announced the coming exit of the Chairman post. With shares around $209.00, this stock is within 1% or so of its 52-week and all-time high of $211.79. Estimates are $3.61 EPS and $25.36 and next quarter estimates are $5.27 EPS and $29.39 billion in revenue. Its services backlog at the end of last quarter was listed as $136 billion.
Johnson & Johnson (NYSE: JNJ) trades at $68.85, within about 2% of its 52-week high of $69.75. Estimates for the drug and medical products giant are $1.21 EPS and $16.95 billion in revenue. For the next quarter estimates are $1.18 EPS and $17.53 billion.
UnitedHealth Group Inc. (NYSE: UNH) is the newest DJIA member now that Kraft is out of the index. The health insurance giant has almost a $60 billion market value and is now expanding by growing into Brazil. The stock is down only about 2% from its 52-week high of $60.75. Earnings estimates are $1.19 EPS and $27.33 billion in sales. For the year 2012, estimates are $4.98 EPS and almost $109.9 billion in sales.
JON C. OGG